Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer

doi:10.5306/wjco.v14.i8.297

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2510)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

985

Figures (1-7)

295

Tables (1-3)

163

Sum=1504

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

122

Download

527

Sum=649

Publishing Process of This Article

Item

Count

Browse

Download

202

Sum=282

Aug 24, 2023 (publication date) through May 13, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Aug 24, 2023; 14(8): 297-310
Published online Aug 24, 2023. doi: 10.5306/wjco.v14.i8.297

Full Size Figure Download Figure

Figure 2 Relationship between six-transmembrane epithelial antigen of the prostate 4 level and clinical stage of gastric cancer patients. STAD: Stomach adenocarcinoma; STEAP4: Six-transmembrane epithelial antigen of the prostate 4.

Citation: Fang ZX, Hou YY, Wu Z, Wu BX, Deng Y, Wu HT, Liu J. Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer. World J Clin Oncol 2023; 14(8): 297-310
URL: https://www.wjgnet.com/2218-4333/full/v14/i8/297.htm
DOI: https://dx.doi.org/10.5306/wjco.v14.i8.297